Details of the Drug Formulations

General Information of Drug (ID: DMIZ6W2)

• Drug Name: Norfloxacin Drug Info
• Synonyms: Baccidal; Barazan; Chibroxin; Fulgram; Lexinor; NFLX; Norflo; Norfloxacine; Norfloxacino; Norfloxacinum; Noroxin; Sebercim; Merck Brand of Norfloxacin; Norfloxacin Merck Brand; AM 0715; AM 715; AM0715; MK 0366; MK 366; MK0366; MK366; AM-0715; AM-715; Chibroxin (TN); Insensye (TN); MK-0366; MK-366; Norflohexal (TN); Norfloxacine [INN-French]; Norfloxacino [INN-Spanish]; Norfloxacinum [INN-Latin]; Norfocin (TN); Noroxin (TN); Nufloxib (TN); Roxin (TN); Utin (TN); Utinor (TN); Apo-Norflox (TN); Norfloxacin (JP15/USP/INN); Norfloxacin [USAN:BAN:INN:JAN]; Chibroxin, MK-366, Baccidal, Sebercim, Zoroxin, Norfloxacin; 1,4-Dihydro-1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid; 1-Ethyl-6-fluor-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-chinolincarbonsaeure; 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid; 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-[1-piperazinyl]-3-quinoline-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid

Indication

Disease Entry	ICD 11	Status	REF
Acute gonococcal cervicitis		Approved	[1]
Acute maxillary sinusitis		Approved	[1]
Anthrax	1B97	Approved	[1]
Bacillary dysentery	1A02	Approved	[1]
Bacterial infection	1A00-1C4Z	Approved	[2]
Bronchitis	CA20	Approved	[1]
Chancroid		Approved	[1]
Chronic tubotympanic suppurative otitis media		Approved	[1]
Cystitis	GC00	Approved	[1]
Endomyometritis		Approved	[1]
Malignant otitis externa caused by Pseudomonas aeruginosa		Approved	[1]
Mycoplasma pneumoniae pneumonia		Approved	[1]
Peritonitis		Approved	[1]
Pneumonia	CA40	Approved	[1]
Prostatitis		Approved	[1]
Pyelonephritis		Approved	[1]
Staphylococcal pneumonia		Approved	[1]
Staphylococcus aureus infection		Approved	[1]
Streptococcal pneumonia		Approved	[1]
Traveler's diarrhea	ME05.1	Approved	[1]
Urinary tract infection	GC08	Approved	[1]
Pneumonia caused by chlamydia		Investigative	[1]
Pneumonia due to Klebsiella pneumoniae	CA40.03	Investigative	[1]

• Therapeutic Class: Antibiotics
• Cross-matching ID:
  PubChem CID: 4539
  ChEBI ID: CHEBI:100246
  CAS Number: 70458-96-7
  TTD ID: D0Q2PE
  VARIDT ID: DR01204
  INTEDE ID: DR1176
  ACDINA ID: D00479

Full List of Drug Formulations Containing This Drug

Norfloxacin 400 mg tablet

Company	Formulation ID	FDA Description
Merck Sharp & Dohme	F15506	Magnesium stearate; Titanium dioxide; Croscarmellose sodium; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Hypromelloses

References

• [1] Norfloxacin FDA Label
• [2] FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 074690.